Total Assets Summary of Azitra, Inc.

Azitra, Inc.'s latest annual total assets in 2023 was 5.11 Million USD , down -28.63% from previous year.
Azitra, Inc.'s latest quarterly total assets in 2024 Q2 was 3.88 Million USD , down -36.02% from previous quarter.
Azitra, Inc. reported annual total assets of 7.16 Million USD in 2022, down -29.74% from previous year.
Azitra, Inc. reported annual total assets of 10.2 Million USD in 2021, down 0.0% from previous year.
Azitra, Inc. reported quarterly total assets of 6.06 Million USD for 2024 Q1, up 18.62% from previous quarter.
Azitra, Inc. reported quarterly total assets of 7.49 Million USD for 2023 Q3, down -23.8% from previous quarter.

Annual Total Assets Chart of Azitra, Inc. (2023 - 2021)

Name	Total Assets	Total Assets Difference
AIM ImmunoTech Inc.	19.38 Million USD	73.606%
Ampio Pharmaceuticals, Inc.	5.73 Million USD	10.818%
Armata Pharmaceuticals, Inc.	109.96 Million USD	95.348%
Actinium Pharmaceuticals, Inc.	81.44 Million USD	93.719%
Can-Fite BioPharma Ltd.	9.98 Million USD	48.789%
Chromocell Therapeutics Corporation	96.39 Thousand USD	-5207.016%
Calidi Biotherapeutics, Inc.	10.01 Million USD	48.942%
CEL-SCI Corporation	30.52 Million USD	83.243%
iBio, Inc.	28.73 Million USD	82.197%
Lineage Cell Therapeutics, Inc.	101.01 Million USD	94.936%
MAIA Biotechnology, Inc.	7.56 Million USD	32.396%
Matinas BioPharma Holdings, Inc.	65.57 Million USD	92.199%
Navidea Biopharmaceuticals, Inc.	4.37 Million USD	-17.016%
NovaBay Pharmaceuticals, Inc.	9.03 Million USD	43.375%
NanoViricides, Inc.	12.82 Million USD	60.106%
Oragenics, Inc.	4.96 Million USD	-3.003%
BiomX Inc.	58.15 Million USD	91.204%
BiomX Inc.	58.15 Million USD	91.204%
Protalix BioTherapeutics, Inc.	84.43 Million USD	93.941%
Palatin Technologies, Inc.	10.74 Million USD	52.38%
Scorpius Holdings, Inc.	51.03 Million USD	89.977%